Literature DB >> 7672895

Life table analysis of the United States' Year 2000 mortality objectives.

I R Rockett1, J H Pollard.   

Abstract

BACKGROUND: The US Year 2000 mortality objectives are model standards cast as targeted changes in age-adjusted cause-specific death rates. This research centred on the projected impact of such changes on life expectancy and the mortality toll for each sex.
METHODS: A computer simulation was conducted using single decrement, multiple decrement and cause-elimination life table techniques, together with a decomposition procedure.
RESULTS: Male and female life expectancy at birth was projected to increase by 1.71 and 1.51 years, respectively, between the designated 1987 baseline and 2000. The leading beneficiaries would be those aged 65 and older, followed by those aged 45-64, and infants. Declines in coronary heart disease, stroke and injury death rates would most influence the projected life expectancy changes, irrespective of sex. Approximately 782,000 male deaths and 730,000 female deaths would be averted under Year 2000 assumptions.
CONCLUSIONS: Life expectancy would be a useful summary measure to incorporate into official evaluations of the Year 2000 mortality objectives. Targeting of excess male mortality in the US and other highly industrialized nations is recommended.

Entities:  

Keywords:  Age Factors; Americas; Causes Of Death; Demographic Analysis; Demographic Factors; Developed Countries; Differential Mortality; Estimation Technics; Length Of Life; Life Expectancy; Life Table Method; Life Tables; Mortality; North America; Northern America; Population; Population Characteristics; Population Dynamics; Population Projection; Research Methodology; Sex Factors; United States

Mesh:

Year:  1995        PMID: 7672895     DOI: 10.1093/ije/24.3.547

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  1 in total

1.  Heller myotomy vs Heller myotomy plus Dor fundoplication: cost-utility analysis of a randomized trial.

Authors:  A Torquati; R Lutfi; L Khaitan; K W Sharp; W O Richards
Journal:  Surg Endosc       Date:  2006-01-25       Impact factor: 4.584

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.